GMP Synthase Antikörper (Middle Region)
Kurzübersicht für GMP Synthase Antikörper (Middle Region) (ABIN2783438)
Target
Alle GMP Synthase (GMPS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
-
Homologie
- Cow: 93%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 93%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against GMPS. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human GMPS
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 693 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- GMP Synthase (GMPS) (Guanine Monophosphate Synthetase (GMPS))
-
Andere Bezeichnung
- GMPS
-
Hintergrund
-
In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.
Alias Symbols: -
Protein Interaction Partner: UBC, SUMO2, SUMO3, TNRC6B, SUMO1, NEDD8, COASY, EFHD2, PPME1, TSTA3, RCN1, RAB1A, PSMD5, PNP, MTAP, ENO2, FBXO6, AGPAT2, VCAM1, ITGA4, FN1, APRT, AHCY, CUL3, SIRT7, SUMO4, USP7, DDA1, PRKAG2, BABAM1, TCEAL1,
Protein Size: 693 -
Molekulargewicht
- 77 kDa
-
Gen-ID
- 8833
-
NCBI Accession
- NM_003875, NP_003866
-
UniProt
- P49915
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-